Authors: Kaltenbach, RF Trainor, G Getman, D Harris, G Garber, S Cordova, B Bacheler, L Jeffrey, S Logue, K Cawood, P Klabe, R Diamond, S Davies, M Saye, J Jona, J Erickson-Viitanen, S

Citation: Rf. Kaltenbach et al., DPC 681 and DPC 684: Potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants, ANTIM AG CH, 45(11), 2001, pp. 3021-3028

Authors: Bacheler, L Jeffrey, S Hanna, G D'Aquila, R Wallace, L Logue, K Cordova, B Hertogs, K Larder, B Buckery, R Baker, D Gallagher, K Scarnati, H Tritch, R Rizzo, C

Citation: L. Bacheler et al., Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy, J VIROLOGY, 75(11), 2001, pp. 4999-5008

Authors: Corbett, JW Ko, SS Rodgers, JD Gearhart, LA Magnus, NA Bacheler, LT Diamond, S Jeffrey, S Klabe, RM Cordova, BC Garber, S Logue, K Trainor, GL Anderson, PS Erickson-Viitanen, SK

Citation: Jw. Corbett et al., Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 43(10), 2000, pp. 2019-2030